First Trust NYSE Arca Biotechnology Index Fund
250 hedge funds and large institutions have $535M invested in First Trust NYSE Arca Biotechnology Index Fund in 2024 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 57 increasing their positions, 88 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less capital invested
Capital invested by funds: $559M → $535M (-$23.6M)
35% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 88
Holders
250
Holding in Top 10
1
Calls
$2.94M
Puts
–
Top Buyers
| 1 | +$6.26M | |
| 2 | +$4.11M | |
| 3 | +$3.28M | |
| 4 |
GWA
GGM Wealth Advisors
Baltimore,
Maryland
|
+$3.17M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$2.49M |
Top Sellers
| 1 | -$8.83M | |
| 2 | -$7.9M | |
| 3 | -$7.68M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.96M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$4.78M |